Resources

An overview of a diagnostic platform that PATH is developing based on nucleic-acid amplification that will require no instrumentation. It has the dual purpose of providing molecular diagnostics at the point of care as well as stabilizing nucleic-acid specimens for further analysis via a centralized surveillance system. Presented at the American Association for Clinical Chemistry 40th Annual Oak Ridge Conference, April 17, 2008; San Jose, CA.

This document summarizes PATH’s work in Indonesia to sustain best practices among health workers in project provinces through a supportive supervision program.

These workshop materials were designed for manufacturers of male latex condoms to introduce and solicit input on the new WHO Prequalification Programme for Male Latex Condoms. The objective is to increase the successful participation of manufacturers, thereby expanding the supplier base and expediting progress toward reproductive health supply security in low- and middle-income countries. If you intend to adapt these materials, it is recommended that experienced facilitators manage each session. For more information, contact info@path.org.

A report on appropriate product specifications and the challenges of introducing a point-of-care multiplexed diagnostic platform in low-resource settings in developing countries. Based on the DxBox platform being developed as part of a public-private consortium lead by the University of Washington. Presented at: Molecular Medicine Tri-Conference, March 25, 2008; San Francisco, CA.

A report on the selection and evaluation of target markers for a multiplex diagnostic platform under development. Based on the DxBox platform being developed as part of a public-private consortium lead by the University of Washington. Presented at the Molecular Medicine Tri-Conference, March 25, 2008; San Francisco, CA.